Empirical studies presenting a stakeholder elicitation study or using MCDA for decision support
17	2014	Haakma W, Steuten LMG, Bojke L, IJzerman MJ. Belief Elicitation to Populate Health Economic Models of Medical Diagnostic Devices in Development. Appl Health Econ Health Policy. 2014 Mar 13;12(3):327–34. [44]
18		Groothuis-Oudshoorn CGM, Fermont JM, van Til JA, IJzerman MJ. Public stated preferences and predicted uptake for genome-based colorectal cancer screening. BMC Med Inform Decis Mak. 2014 Mar 19;14(1):18. [56]
19	2015	de Graaf G, Postmus D, Buskens E. Using Multicriteria Decision Analysis to Support Research Priority Setting in Biomedical Translational Research Projects. BioMed Research International. 2015;2015(12):1–9. [67]
20	2016	Middelkamp HHT, van der Meer AD, Hummel JM, Stamatialis DF, Mummery CL, IJzerman MJ: Organs-on-Chips in Drug Development: The Importance of Involving Stakeholders in Early Health Technology Assessment. Applied In Vitro Toxicology. 2016 Feb 19;:aivt.2015.0029. [42]
21		Fermont JM, Douw KHP, Vondeling H, IJzerman MJ. Ranking medical innovations according to perceived health benefit. Health Policy and Technology. 2016; 5(2): 156-165 [68]
22		Joosten SEP, Retèl VP, Coupé VMH, van den Heuvel MM, Van Harten WH. Scenario drafting for early technology assessment of next generation sequencing in clinical oncology. BMC Cancer. 2016 Feb 6;16:66. [69]